Abstract
This review addresses mainly the polyamine levels in various tissues and regional brain of (intact) rats treated with various types of anticancer drugs and those in diverse foods. Results indicate that the most effective combination therapy for cancer patients based on polyamine level is a polyamine-free diet coupled with drugs that reduce the amine in cancer-bearing host tissues.
Keywords: Polyamine, anti-cancer drug, food, cancer, rat, human, therapy
Current Drug Therapy
Title: Effective Anticancer Drug and Food Choices Based on Polyamine Levels in Cancer Tissues
Volume: 4 Issue: 3
Author(s): Satoru Watanabe, Sumika Nagase, Shoichi Sato and Seitaro Ohkuma
Affiliation:
Keywords: Polyamine, anti-cancer drug, food, cancer, rat, human, therapy
Abstract: This review addresses mainly the polyamine levels in various tissues and regional brain of (intact) rats treated with various types of anticancer drugs and those in diverse foods. Results indicate that the most effective combination therapy for cancer patients based on polyamine level is a polyamine-free diet coupled with drugs that reduce the amine in cancer-bearing host tissues.
Export Options
About this article
Cite this article as:
Watanabe Satoru, Nagase Sumika, Sato Shoichi and Ohkuma Seitaro, Effective Anticancer Drug and Food Choices Based on Polyamine Levels in Cancer Tissues, Current Drug Therapy 2009; 4 (3) . https://dx.doi.org/10.2174/157488509789054992
DOI https://dx.doi.org/10.2174/157488509789054992 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alternative Methods in Eradicating Helicobacter Pylori Infection
Current Pharmaceutical Analysis Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design Design and Development of Nanoparticulate Dosage Form of Telmisartan for Bioavailability Enhancement
Micro and Nanosystems Cell Death: Tipping the Balance of Autoimmunity and Tissue Repair
Current Pharmaceutical Design New Insights Into the Molecular Mechanisms of Action of Bisphosphonates
Current Pharmaceutical Design Stem Cells, Self-Renewal and Cancer of the Gastric Epithelium
Current Medicinal Chemistry GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Current Pharmaceutical Design Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Base Excision Repair, the Redox Environment and Therapeutic Implications
Current Molecular Pharmacology Perturbation of HSP Network in MCF-7 Breast Cancer Cell Line Triggers Inducible HSP70 Expression and Leads to Tumor Suppression
Anti-Cancer Agents in Medicinal Chemistry Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity
Letters in Drug Design & Discovery Chemical Constituents and Antitumor Mechanisms of <i>Artemisia</i>
Anti-Cancer Agents in Medicinal Chemistry Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Recombinant Secretory Immunoglobulin A in Passive Immunotherapy: Linking Immunology and Biotechnology
Current Pharmaceutical Biotechnology Exploring Single Nucleotide Polymorphisms in ITGAV for Gastric, Pancreatic and Liver Malignancies: An Approach Towards the Discovery of Biomarker
Combinatorial Chemistry & High Throughput Screening